ACUMEN PHARMACEUTICALS INC. - COMMON STOCK
1.8000
24-12月-24 11:55:33
15 分の遅延
株式
+0.0300
+1.69%
本日の幅
1.7300 - 1.8300
ISIN
N/A
ソース
NASDAQ
-
08 5 2024 07:00:00 提供 Nasdaq GlobeNewswire
-
Acumen Pharmaceuticals to Report First Quarter Results on May 14, 2024
07 5 2024 15:00:00 提供 Nasdaq GlobeNewswire
-
16 4 2024 07:00:00 提供 Nasdaq GlobeNewswire
-
04 4 2024 07:00:00 提供 Nasdaq GlobeNewswire
-
26 3 2024 06:00:00 提供 Nasdaq GlobeNewswire
-
19 3 2024 15:00:00 提供 Nasdaq GlobeNewswire
-
Acumen Pharmaceuticals to Participate in the Stifel 2024 CNS Days
12 3 2024 15:00:00 提供 Nasdaq GlobeNewswire
-
Acumen Pharmaceuticals Appoints Dr. James Doherty as President and Chief Development Officer
01 2 2024 06:00:00 提供 Nasdaq GlobeNewswire
-
Acumen Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference
04 1 2024 15:15:20 提供 Nasdaq GlobeNewswire
-
Acumen Pharmaceuticals Reports Third Quarter 2023 Financial Results and Business Highlights
13 11 2023 06:00:00 提供 Nasdaq GlobeNewswire
-
Acumen Pharmaceuticals Secures $50.0 Million Credit Facility with K2 HealthVentures
13 11 2023 06:00:00 提供 Nasdaq GlobeNewswire
-
Acumen Pharmaceuticals to Participate in the Stifel Healthcare Conference
07 11 2023 15:01:00 提供 Nasdaq GlobeNewswire
-
Acumen Pharmaceuticals to Report Third Quarter Financial Results on November 13, 2023
06 11 2023 15:01:00 提供 Nasdaq GlobeNewswire
-
06 11 2023 06:30:00 提供 Nasdaq GlobeNewswire
-
Acumen Pharmaceuticals to Participate in the UBS Biopharma Conference
02 11 2023 15:00:00 提供 Nasdaq GlobeNewswire